Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0151744 (
myocardial ischemia
)
31,282
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Taurine, which is found at high concentration in the heart, exerts several protective actions on myocardium. Physically, the high level of taurine in heart is maintained by a taurine transporter (TauT), the expression of which is suppressed under ischemic insult. Although taurine supplementation upregulates TauT expression, elevates the intracellular taurine content and ameliorates the ischemic injury of cardiomyocytes (CMs), little is known about the regulatory mechanisms of taurine governing TauT expression under ischemia. In this study, we describe the TonE (tonicity-responsive element)/
TonEBP
(TonE-binding protein) pathway involved in the taurine-regulated TauT expression in ischemic CMs. Taurine inhibited the ubiquitin-dependent proteasomal degradation of
TonEBP
, promoted the translocation of
TonEBP
into the nucleus, enhanced TauT promoter activity and finally upregulated TauT expression in CMs. In addition, we observed that
TonEBP
had an anti-apoptotic and anti-oxidative role in CMs under ischemia. Moreover, the protective effects of taurine on
myocardial ischemia
were
TonEBP
dependent. Collectively, our findings suggest that
TonEBP
is a core molecule in the protective mechanism of taurine in CMs under ischemic insult.
...
PMID:TonEBP modulates the protective effect of taurine in ischemia-induced cytotoxicity in cardiomyocytes. 2667 69